Trial Profile
An observational, multicenter study investigating efficacy and safety of perindopril/amlodipine fixed dose combination in hypertensive patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2017
Price :
$35
*
At a glance
- Drugs Perindopril/amlodipine (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 02 May 2017 Results published in the American Journal of Cardiovascular Drugs
- 21 Nov 2016 New trial record